Tiziana Life Sciences strengthens intranasal foralumab development with Renaissance Lakewood partnership
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA), a clinical-stage biotechnology company focused on immunomodulation therapies, has announced a strategic partnership with Renaissance Lakewood LLC, a leading ... Read More
OSR Holdings completes merger, set to begin Nasdaq trading on February 18
OSR Holdings, Inc. has officially completed its business combination with OSR Holdings Co., Ltd., marking a pivotal milestone in its expansion within the global healthcare ... Read More